(Q45996791)

18 December 2017

title

The role of PGE2-associated inflammatory responses in gastric cancer development. (English)

1 reference

18 December 2017

0 references

Hiroko Oshima

1

1 reference

18 December 2017

Masanobu Oshima

series ordinal

2

1 reference

18 December 2017

publication date

11 October 2012

1 reference

18 December 2017

Seminars in Immunopathology

published in

1 reference

18 December 2017

volume

35

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

139-150

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00281-012-0353-5

exact match

0 references

cites work

Infections as a major preventable cause of human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

21 January 2018

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

The role of COX-2 in intestinal inflammation and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Mouse models of gastric tumors: Wnt activation and PGE2 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

COX selectivity and animal models for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Systematic review of the association between circulating interleukin-6 (IL-6) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Wnt signaling in the intestinal epithelium: from endoderm to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Wnt signaling and gastrointestinal tumorigenesis in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

cagA+ Helicobacter pylori induces greater levels of prostaglandin E2 than cagA- strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Interferon gamma induction of gastric mucous neck cell hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Prostaglandin E₂ signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Role of beta-arrestin 1 in the metastatic progression of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

ADAMs in cancer cell proliferation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Roles of small RNAs in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

MicroRNAs in inflammation and response to injuries induced by environmental pollution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

MicroRNA-155 is induced during the macrophage inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

p53 represses c-Myc through induction of the tumor suppressor miR-145

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Aspirin and the Risk of Colorectal Cancer in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0353-5

Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis

21 January 2018

1 reference

12 December 2020

Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer.

1 reference

12 December 2020

Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice

1 reference

12 December 2020

Tumour necrosis factor and cancer

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human gastric carcinoma

1 reference

12 December 2020

Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer

1 reference

12 December 2020

Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin

1 reference

12 December 2020

Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies

1 reference

12 December 2020

beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.

1 reference

12 December 2020

Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps

1 reference

12 December 2020

Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

1 reference

12 December 2020

Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland

1 reference

12 December 2020

Combinatorial chemoprevention of intestinal neoplasia

1 reference

12 December 2020

10.1007/S00281-012-0353-5

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1049709968

0 references

1 reference

18 December 2017